Literature DB >> 22071660

Analgesic and anti-inflammatory effect of aqueous extract of the stem bark of Allanblackia gabonensis (Guttiferae).

Edwige V Ymele1, A Bertrand Dongmo, Théophile Dimo.   

Abstract

Allanblackia gabonensis (Guttiferae) is a plant used in the African traditional medicine as remedies against pain, rheumatism, inflammations. In the present work, the analgesic effect of aqueous extract has been evaluated using acetic acid, formalin, hot-plate test, tail immersion and paw-pressure test. The anti-inflammatory effect of this extract was also investigated on carrageenan, histamine or serotonin induced by paw oedema. Aqueous extract of stem bark of A. gabonensis administrated p.o. showed significant activity against paw oedema induced by carrageenan, with a maximum percentage of inhibition reaching the 74.01% at the preventive test at a dose of 200 mg/kg. A. gabonensis exhibited a significant reduction of paw oedema induced by both histamine and serotonin with a maximal inhibition of 56.94% (200 mg/kg) and 40.83% (100 mg/kg), respectively. It showed significant protective effects against chemical stimuli (acetic acid and formalin) in the mouse. Administered orally at the doses of 100-400 mg/kg, exhibited protective effect of at least 69.78% on the pain induced by acetic acid and also reduced first (67.18% at 200 mg/kg) and second (83.87% at 400 mg/kg) phase of pain-induced par formalin. It also produced a significant increase of the threshold of sensitivity to pressure and hot plate-induced pain in the rats. These results suggest a peripheral and central analgesic activities as well as an anti-inflammatory effect of the stem bark of A. gabonensis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22071660     DOI: 10.1007/s10787-011-0096-2

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  26 in total

1.  Effect of Psidium guajava leaves on some aspects of the central nervous system in mice.

Authors:  H M Shaheen; B H Ali; A A Alqarawi; A K Bashir
Journal:  Phytother Res       Date:  2000-03       Impact factor: 5.878

2.  Analgesic triterpenes from Sebastiania schottiana roots.

Authors:  M Gaertner; L Müller; J F Roos; G Cani; A R Santos; R Niero; J B Calixto; R A Yunes; F Delle Monache; V Cechinel-Filho
Journal:  Phytomedicine       Date:  1999-03       Impact factor: 5.340

3.  Prenylated xanthone derivatives with antiplasmodial activity from Allanblackia monticola STANER L.C.

Authors:  Anatole Guy Blaise Azebaze; Michèle Meyer; Alexis Valentin; Edwige Laure Nguemfo; Zacharias Tanee Fomum; Augustin Ephrem Nkengfack
Journal:  Chem Pharm Bull (Tokyo)       Date:  2006-01       Impact factor: 1.645

4.  Anti-inflammatory activity of Trichodesma indicum root extract in experimental animals.

Authors:  James B Perianayagam; S K Sharma; K K Pillai
Journal:  J Ethnopharmacol       Date:  2005-11-21       Impact factor: 4.360

5.  Antinociceptive and anti-inflammatory activities of Acacia pennata wild (Mimosaceae).

Authors:  A B Dongmo; T Nguelefack; M A Lacaille-Dubois
Journal:  J Ethnopharmacol       Date:  2005-04-08       Impact factor: 4.360

6.  Anti-inflammatory activity of lupeol and lupeol linoleate in rats.

Authors:  T Geetha; P Varalakshmi
Journal:  J Ethnopharmacol       Date:  2001-06       Impact factor: 4.360

7.  Analgesic and anti-inflammatory activity of Lactuca sativa seed extract in rats.

Authors:  Mohammad Sayyah; Naghmeh Hadidi; Mohammad Kamalinejad
Journal:  J Ethnopharmacol       Date:  2004-06       Impact factor: 4.360

8.  Release of prostaglandins E and F in an algogenic reaction and its inhibition.

Authors:  R Deraedt; S Jouquey; F Delevallée; M Flahaut
Journal:  Eur J Pharmacol       Date:  1980-01-11       Impact factor: 4.432

9.  Vasodilating properties of the stem bark extract of Mitragyna ciliata in rats and guinea pigs.

Authors:  A Dongmo; M A Kamanyi; P V Tan; M Bopelet; W Vierling; H Wagner
Journal:  Phytother Res       Date:  2004-01       Impact factor: 5.878

10.  Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study.

Authors:  G Singh; D R Ramey; D Morfeld; H Shi; H T Hatoum; J F Fries
Journal:  Arch Intern Med       Date:  1996-07-22
View more
  5 in total

1.  Antiplasmodial activity of some phenolic compounds from Cameroonians Allanblackia.

Authors:  Anatole Guy Blaise Azebaze; Jean Emmanuel Mbosso Teinkela; Edwige Laure Nguemfo; Alexis Valentin; Alain Bertrand Dongmo; Juliette Catherine Vardamides
Journal:  Afr Health Sci       Date:  2015-09       Impact factor: 0.927

Review 2.  Ethnopharmacological Survey of Plants Used in the Traditional Treatment of Gastrointestinal Pain, Inflammation and Diarrhea in Africa: Future Perspectives for Integration into Modern Medicine.

Authors:  Timo D Stark; Dorah J Mtui; Onesmo B Balemba
Journal:  Animals (Basel)       Date:  2013-03-04       Impact factor: 2.752

3.  Antibacterial and antibiotic resistance modifying activity of the extracts from Allanblackia gabonensis, Combretum molle and Gladiolus quartinianus against Gram-negative bacteria including multi-drug resistant phenotypes.

Authors:  Aimé G Fankam; Jules R Kuiate; Victor Kuete
Journal:  BMC Complement Altern Med       Date:  2015-06-30       Impact factor: 3.659

4.  Cytotoxicity and Modes of Action of the Methanol Extracts of Six Cameroonian Medicinal Plants against Multidrug-Resistant Tumor Cells.

Authors:  Victor Kuete; Aimé G Fankam; Benjamin Wiench; Thomas Efferth
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-23       Impact factor: 2.629

Review 5.  A systematic review for anti-inflammatory property of clusiaceae family: a preclinical approach.

Authors:  Mônica Santos de Melo; Jullyana de Souza Siqueira Quintans; Adriano Antunes de Souza Araújo; Marcelo Cavalcante Duarte; Leonardo Rigoldi Bonjardim; Paulo Cesar de Lima Nogueira; Valéria Regina de Souza Moraes; João Xavier de Araújo-Júnior; Eurica Adélia Nogueira Ribeiro; Lucindo José Quintans-Júnior
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-26       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.